Tirzepatide (Mounjaro) is the newest diabetes drug in 2024, combining two hormones to lower blood sugar and promote weight loss. It outperforms older meds like Ozempic and is now available on the NHS in the UK for eligible patients.
Read MoreBy Rahul Chatterjee | 0 Comments | February 27, 2026
Tirzepatide (Mounjaro) is the newest diabetes drug in 2024, combining two hormones to lower blood sugar and promote weight loss. It outperforms older meds like Ozempic and is now available on the NHS in the UK for eligible patients.
Read MoreTirzepatide (Mounjaro) is the newest diabetes drug in 2024, combining two hormones to lower blood sugar and promote weight loss. It outperforms older meds like Ozempic and is now available on the NHS in the UK for eligible patients.
Explore top alternatives to metformin, including SGLT2 inhibitors, GLP‑1 agonists, and DPP‑4 inhibitors, with benefits, side effects, and how to choose the right diabetes medication.
Wegovy is expensive, but Ozempic - the same active ingredient at a lower price - is a proven, legal, and safer alternative for weight loss. Learn how to get it safely and avoid fake generics.
The #1 secret to weight loss isn't calorie counting or extreme diets-it's fixing your hormones, eating whole foods, and building habits that last. Discover what really works.
The 30/30/30 rule is a popular approach in the weight loss community, providing a structured method to balance diet, exercise, and lifestyle changes. By focusing on a holistic approach, this rule breaks down strategies into manageable parts to help individuals lose weight more sustainably. With an emphasis on consistency and balance, the 30/30/30 rule can be an excellent way to make lasting changes. Explore how this methodology can aid in efficient weight management and promote healthier living.